Suscripción a Biblioteca: Guest
Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones
Critical Reviews™ in Therapeutic Drug Carrier Systems
Factor de Impacto: 2.9 Factor de Impacto de 5 años: 3.72 SJR: 0.736 SNIP: 0.551 CiteScore™: 2.43

ISSN Imprimir: 0743-4863
ISSN En Línea: 2162-660X

Volumes:
Volumen 36, 2019 Volumen 35, 2018 Volumen 34, 2017 Volumen 33, 2016 Volumen 32, 2015 Volumen 31, 2014 Volumen 30, 2013 Volumen 29, 2012 Volumen 28, 2011 Volumen 27, 2010 Volumen 26, 2009 Volumen 25, 2008 Volumen 24, 2007 Volumen 23, 2006 Volumen 22, 2005 Volumen 21, 2004 Volumen 20, 2003 Volumen 19, 2002 Volumen 18, 2001 Volumen 17, 2000 Volumen 16, 1999 Volumen 15, 1998 Volumen 14, 1997 Volumen 13, 1996 Volumen 12, 1995

Critical Reviews™ in Therapeutic Drug Carrier Systems

DOI: 10.1615/CritRevTherDrugCarrierSyst.v24.i1.30
pages 63-92

Oral Colon-Specific Drug Delivery of Protein and Peptide Drugs

Vivek Ranjan Sinha
University Institute of Pharmaceutical Sciences, UGC Centre for Advanced Studies, Panjab University, Chandigarh, India, 160014
Asmita Singh
University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India
Ruchita V. Kumar
University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India
Sanjay Singh
Department of Pharmaceutics, IT, BHU, Varanasi, India
Rachana Kumria
Ind-Swift Ltd. Parwanoo, India
J. R. Bhinge
University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh; and Center with Potential for Excellence in Biomedical Sciences, Panjab University, Chandigarh, India

SINOPSIS

With the advent of new technologies and radical growth in the field of biotechnology, dozens of protein and peptide drugs have been marketed. However, there are several challenges for successful delivery of such molecules. A number of routes have been used for the delivery of these fragile molecules by exploring various novel delivery technologies, including microspheres, liposomes, gel spheres, nano-spheres, niosomes, microemulsions, use of permeation enhancers, use of protease inhibitors, etc. But the route that has attracted the attention of worldwide drug delivery scientists is the oral route due to its various advantages. Even though the proteolytic activity is higher in a few segments of the gastrointestinal tract (GIT), this route has certain segments that have lower proteolytic activity, for example, the colon. The colon has captured attention as a site for the delivery of these molecules because of its greater responsiveness to absorption enhancers, protease inhibitors, and novel bioadhesive and biodegradable polymers. Although the success rate of these approaches, when used alone is pretty low, when used in combinations, these agents have demonstrated wonders in increasing the drug bioavailability. This review focuses on the challenges, pharmaceutical concepts, and approaches involved in the delivery of these fragile molecules, specifically to the colon. This review also includes studies conducted on colonic targeting of such drugs. Further studies may lead to improvements in therapy using protein/peptide drugs and refinements in the technology of colon-specific drug delivery.


Articles with similar content:

PEGylation: An Approach for Drug Delivery. A Review
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.25, 2008, issue 5
Aviral Jain, Sanjay Kumar Jain
Transcending the Skin Barrier to Deliver Peptides and Proteins Using Active Technologies
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.29, 2012, issue 4
Haripriya Kalluri, Anushree Herwadkar, Neha Singh, Ajay K. Banga, Advait Badkar
Advances in Buccal Drug Delivery
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.22, 2005, issue 3
Raj Birudaraj, Bhaskara R. Jasti, Xiaoling Li, Ravichandran Mahalingam
Therapeutic Opportunities in Colon-Specific Drug-Delivery Systems
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.24, 2007, issue 2
Avani Amin, Mayur M. Patel, Tejal Shah
Drug-Polymer Conjugates Containing Acid-Cleavable Bonds
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.16, 1999, issue 3
Mark Thomas Schutte, Felix Kratz, Ulrich Beyer